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Introduction.This study aimed to explore the predictors ofmortality from scrub typhus infection in patients requiring intensive care
unit (ICU) admission.Materials andMethods.A retrospective study was conducted on 120 patients with serum ELISA IgM positive
for scrub typhus (optical density ≥ 0.5) admitted at the medical ICU of Chitwan Medical College Teaching Hospital between April
2016 and September 2017. Data was extracted from patient medical records and electronic database of the hospital. The outcome
measurement was mortality (Yes/No) due to the infection. A multivariate binary logistic regression analysis (𝑝 < 0.10) using
potential variables from bivariate analysis (𝑝 < 0.25) was adjusted to predict the mortality. Results. The mortality rate was 20%
(24/120). Factors associated with mortality, as found using bivariate analysis, were heart rate > 100/minute (𝑝 < 0.001), systolic
blood pressure< 90mmHg (𝑝 = 0.025), diastolic blood pressure< 60mmHg (𝑝 = 0.032), serum creatinine> 1.4mg/dl (𝑝 < 0.001),
acute kidney injury requiring dialysis (𝑝 = 0.029), acute respiratory distress syndrome (𝑝 < 0.001), and shock requiring vasopressor
(𝑝 < 0.001). Regression analysis showed age (odds ratio [OR] = 1.063; 95% CI = 1.010–1.118; 𝑝 = 0.019) and serum creatinine (OR =
1.063; 95% CI = 1.010–1.118; 𝑝 = 0.019) as significant predictors of poor outcome. Conclusion.Older age and high serum creatinine
were found to be independent predictors of poor outcome in patients with scrub typhus admitted in medical ICU.
1. Introduction
Scrub typhus is a reemerging zoonotic bacterial infection in
the “tsutsugamushi triangle” region of South and Southeast
Asia, the Asian Pacific Rim, and Northern Australia [1–5]. It
is an acute, febrile illness caused by Orientia (formerly Rick-
ettsia) tsutsugamushi, an obligate intracellular Gram-negative
bacterium [6]. It was estimated that about one million people
are affected with scrub typhus annually [7]. It is being
recognized as an important cause of acute undifferentiated
febrile illness in recent times. Though it was first reported in
Nepal in early 1981 (19/188, 10.10%) [8], it was not identified till
2004, when a study in Patan Hospital, Kathmandu, reported
that 3.2% (28/876) of patients suspected for typhoid fever
had serology positive for scrub typhus [9]. Another study
in 2007 also reported the presence of scrub typhus in 22%
(𝑛 = 103) of patients with fever [10]. Three months after
the devastating earthquake in Nepal (August 2015), scrub
typhus was officially confirmed as having magnitudes of fatal
outbreak [5]. Moreover, Chitwan, a district in the southern
part of the country, experienced an outbreak of the disease
in 2015, causing several morbidities and mortalities. Despite
this, it is still one of the underrecognized and neglected
diseases in the world, including Nepal [5, 11].
Studies inNepal have reportedmortality rate due to scrub
typhus ranging from 1.7% to 7.92% [5, 12, 13]. A systematic
review reported a median case fatality rate of 1.4% (range
0–33.3%) in treated patients with scrub typhus infection
[14]. Studies from different parts of the world reported
several predictors for mortality in patients with scrub typhus
infection [15–19]. Similarly, a previous study from Nepal
reported that development of shock, presence of acute kidney
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injury (AKI) at the time of admission, pneumonia, and
requirement of intensive care unit (ICU) were predictors
of mortality requiring hospital admission [13]. Moreover, a
study in tertiary care teaching hospital of India reported that
APACHE-II score and duration of fever were independent
predictors of mortality in scrub typhus infection requiring
intensive care admission [20]. However, there was a paucity
of data on predictors of mortality in scrub typhus infection,
especially requiring intensive care admission, from Nepal.
This study aimed to find out the predictors of mortality in
scrub typhus infection requiring intensive care admission in
tertiary healthcare centre of Nepal.
2. Materials and Methods
This is a retrospective study including patients with scrub
typhus infection aged 16 years or more admitted in Medi-
cal Intensive Care Unit (MICU) of Chitwan Medical Col-
lege Teaching Hospital (CMCTH) between April 2016 and
September 2017. CMCTH is located in the southern part of
Nepal and is a 650-bedded multispecialty hospital with sev-
enteen beds in MICU. The ethical approval of this study was
obtained from Institutional Review Committee of Chitwan
Medical College (ref. number CMC-IRC: 2074/075: 35) and a
confidentiality agreement with ChitwanMedical College was
signed by all researchers using themedical records of patients
and electronic dataset. Medical records of the patients with
serum ELISA IgM positive for scrub typhus (optical density
≥ 0.5), using ELISA kit manufactured by InBios International
Inc., USA, were reviewed for the study. Coinfected patients
with dengue, influenza, malaria, leptospirosis, and typhoid
fever were excluded. Sociodemographic information: age and
sex; clinical features: duration of fever, signs and symptoms,
comorbidities, heart rate (HR), systolic blood pressure (SBP),
and diastolic blood pressure (DBP); organ dysfunctions; and
complications were retrieved from patient medical records.
Similarly, electronic database was used to collect the lab-
oratory information that included hemoglobin level, white
blood cell count (WBC), platelets count, bilirubin level, total
protein level, albumin level, transaminases levels, and serum
creatinine level. The outcome measurement was mortality
(Yes/No).
Statistical analysis was performed by using IBM SPSS
version 20 (IBMCorporation,Armonk,NY,USA).Normality
was confirmed using Shapiro-Wilk test. Descriptive statistics
were performed for all study variables. Chi-square and
Mann–Whitney 𝑈 tests, where appropriate, were performed
for bivariate analysis to determine the level of association
with outcome measurement. A multivariate binary logistic
regression analysis (𝑝 < 0.10) using potential variables from
bivariate analysis (𝑝 < 0.25) was adjusted to predict the
mortality. For all statistical analysis, 𝑝 < 0.05 was considered
as statistically significant.
3. Results
Out of 120 patients, 42 (35%) were males. The median
[interquartile range (IQR)] age was 41 (28.8) years. Majority
of the patients had fever for less than seven days (64, 53.3%);
Table 1: Baseline characteristics (𝑛 = 120).
Characteristics 𝑛 (%)
aAge in years 41 (28.8)
Sex (female) 78 (65.0)
Duration of fever
<7 days 64 (53.3)
7–14 days 51 (42.5)
15–21 days 5 (4.2)
HR (>100/minute) 84 (70.0)
SBP (<90mmHg) 58 (48.3)
DBP (<60mmHg) 59 (49.2)
Haemoglobin level (<12mg/dl) 105 (87.5)
WBC count (>11,000/mm3) 75 (62.5)
Platelets count (<100,000/mm3) 91 (75.8)
Bilirubin level (>1.5mg/dl) 48 (40.0)
Total protein level (<6 gm/dl) 78 (65.0)
Albumin level (<3.5 gm/dl) 93 (77.5)
Transaminase level (>120 IU/l) 65 (54.2)
Serum creatinine level (>1.4mg/dl) 45 (37.5)
ARDS 55 (45.8)
Shock requiring vasopressor 70 (58.3)
AKI requiring dialysis 7 (5.8)
Meningoencephalitis 13 (10.8)







aMedian [interquartile range (IQR)], ARDS: acute respiratory distress
syndrome; AKI: acute kidney injury; DBS: diastolic blood pressure; HR:
heart rate; SBP: systolic blood pressure; WBC: white blood cell.
heart rate more than 100 beats per minute (84, 70.0%);
hemoglobin level less than 12mg/dl (105, 87.5%); WBC count
more than 11000 per mm3 (75, 62.5%); platelets count less
than 100000 per mm3 (91, 75.8%); total protein level less than
6 g per dl (78, 65.0%); albumin level less than 3.5 g per dl (93,
77.5%); and shock requiring vasopressor (70, 58.3%). Fifty-
five patients (45.8%) had acute respiratory distress syndrome
(ARDS) and two-fifths patients had bilirubin level more than
1.5mg/dl. Similarly, dialysis was performed in seven patients
(5.8%). Most common complication was pneumonia (27,
22.5%). Others documented complications were meningoen-
cephalitis (13, 10.8%), myocarditis (8, 6.7%), gastrointestinal
bleeding (2, 1.7%), and arrhythmia (1, 0.8%). Of 120 patients,
96 (80.0%) patients recovered after treatment, while others
(24, 20.0%) died (Table 1).
Most common comorbidities documented in our study
was hypertension (8, 6.7%), followed by diabetes (6, 5.0%)
and COPD (5, 4.2%). Details of other comorbidities are
depicted in Figure 1.
The signs and symptoms of patients as seen in our study
have been illustrated in Figure 2. Almost all the patients (119,























Co-morbidities in scrub typhus positive patients (n = 120)
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Figure 1: Comorbidities in scrub typhus positive patients. COPD:
chronic obstructive pulmonary disease; CVA: cardiovascular acci-

























































Signs and symptoms of  scrub typhus positive patients (n = 120)
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Figure 2: Signs and symptoms of scrub typhus positive patients.
99.2%) had fever. Other chief complaints were vomiting (42,
35%), abdominal pain (30, 25%), shortness of breath (24,
20.0%), and headache (23, 19.2%).
Bivariate analysis demonstrated that statistically signifi-
cant factors that were associated with mortality due to scrub
typhus were HRmore than 100 beats per minute (𝑝 < 0.001);
SBP less than 90mmHg (𝑝 = 0.025); DBP less than 60mmHg
(𝑝 = 0.032); serum creatinine level more than 1.4mg per
dl (𝑝 < 0.001); AKI requiring dialysis (𝑝 = 0.029); ARDS
(𝑝 < 0.001); and shock requiring vasopressor (𝑝 < 0.001)
(Table 2).
Table 3 shows the model, developed from multivariate
logistic regression analysis of explanatory variables [𝑝 <
0.25 from Table 2: age (years), duration of fever (days), HR
(>100/minute), SBP (<90mmHg), DBP (<60mmHg), WBC
count (>11000 per mm3), platelets count (<100000 per mm3),
bilirubin level (>1.5mg/dl), total protein level (<6 g/dl),
serum creatinine level (>1.4mg/dl), AKI requiring dialysis,
ARDS, shock requiring vasopressor, and meningoencephali-
tis], used to predict mortality of patients with scrub typhus.
The model shows that age and creatinine were statistically
significant predictors of mortality of ICU-admitted patients
with scrub typhus infection. The odds of mortality for
patients with scrub typhus admitted in ICU were higher for
older patients and higher serum creatinine level. The model
depicts that one year increase in age increases the odds of
mortality by 1.063 times (𝑝 = 0.019; 95% CI = 1.010 to 1.118).
However, thosewith serumcreatinine level less than 1.4mg/dl
have 0.089 times lower odds of mortality compared to those
with serum creatinine level more than 1.4mg/dl (𝑝 = 0.004;
95% CI = 0.017 to 0.463).
4. Discussion
Scrub typhus is considered as one of the neglected diseases in
the world, including Nepal [5, 11], with median case fatality
rate of 1.4% (range 0–33.3%) [14]. Overall, mortality rate in
our study was 20%, which is lower than that reported by a
similar study in India (24.1%) [20]. Such high mortality rate
might be due to the delayed arrival in hospitals. As a result,
patients might have developed multiple organ failure before
initiating therapy, primarily doxycycline. Moreover, clinical
failure of doxycycline has also been reported [21]. However,
these issues need further exploration before reaching conclu-
sion in our setting.
Difference has been observed between median ages of
the patients with respect to outcomes in this study. However,
this difference was not statistically significant in bivariate
analysis. Similar results were observed in other studies [16,
17, 22], while some studies have indicated that increasing age
is associated with death [20, 23, 24]. Onmultivariate analysis,
age was observed to be a statistically significant predictor of
mortality in our study, suggesting that increase in one year of
age increases the odds ofmortality by 1.063. Outcomewas not
associated with the sex of the patients in this study, and this
finding is consistent with other studies [16, 20, 22, 24].
Studies have shown an association between duration of
illness andmortality, indicating that shorter duration leads to
poor outcome [17, 20]. It has also been reported that shorter
duration of illness increases the risk of mortality [Relative
Risk (RR) = 0.82 (95% CI = 0.67–0.99) to RR = 0.9 (95% CI
= 0.82–0.96)] [15, 17] and lesser duration of fever increases
the odds of mortality (OR = 0.75; 95% CI = 0.6–0.9) [20].
However, study conducted by Peter et al. did not observe
such association [22], and our study also found similar
results. Moreover, we were unable to evaluate the effect of
appropriate antibiotic on the mortality prior to treatment.
HR (>100/minute), SBP (<90mmHg), andDBP (<60mmHg)
were associated with poor outcomes in our study; however,
these effects were not observed on multivariate analysis.
Although bivariate analysis has shown an association of mor-
tality with HR (>100/minute) [19] and SBP (<90mmHg) [19,
24], a study conducted byThipmontree et al. in Thailand has
found no significant association with HR [24]. Furthermore,
studies demonstrate that SBP (<90mmHg) increases the risk
of mortality by 1.7 (95% CI 0.43–6.8) to 2.8 (95% CI 1.5–5.3)
times [15, 17].
Our study did not show a significant association between
hemoglobin level (<12mg/dl) and mortality, which is similar
4 Interdisciplinary Perspectives on Infectious Diseases




𝑛 (%) 𝑛 (%)
aAge in years 40.0 (30.8) 46.5 (31.8) 0.114
Sex (female) 62 (79.5) 16 (20.5) 1.000
Duration of fever
<7 days 48 (75.0) 16 (25.0)
0.1497–14 days 43 (84.3) 8 (15.7)
15–21 days 5 (100.0) 0
HR (>100/minute) 61 (72.6) 23 (27.4) <0.001∗∗
SBP (<90mmHg) 41 (70.7) 17 (29.3) 0.025∗
DBP (<60mmHg) 42 (71.2) 17 (28.8) 0.032∗
Hemoglobin level (<12mg/dl) 83 (79.0) 22 (21.0) 0.733
WBC count (>11000 per mm3) 57 (76.0) 18 (24.0) 0.239
Platelets count (<100000 per mm3) 70 (76.9) 21 (23.1) 0.220
Bilirubin level (>1.5mg/dl) 34 (70.8) 14 (29.2) 0.069
Total protein level (<6 g/dl) 59 (75.6) 19 (24.4) 0.165
Albumin level (<3.5 g/dl) 72 (77.4) 21 (22.6) 0.299
Transaminase level (>120 IU/l) 52 (80.0) 13 (20.0) 1.000
Serum creatinine level (>1.4mg/dl) 26 (57.8) 19 (42.2) <0.001∗∗
AKI requiring dialysis 3 (42.9) 4 (57.1) 0.029∗
ARDS 31 (56.4) 24 (43.6) <0.001∗∗
Shock requiring vasopressor 46 (65.7) 24 (34.3) <0.001∗∗
Meningoencephalitis 8 (61.5) 5 (38.5) 0.113
GI bleeding 1 (50.0) 1 (50.0) 0.361
Pneumonia 24 (88.9) 3 (11.1) 0.299
Arrhythmia 1 (100.0) 0 (0) 1.000
Myocarditis 4 (50.0) 4 (50.0) 0.500
aMedian [interquartile range (IQR)], ARDS: acute respiratory distress syndrome; AKI: acute kidney injury; DBS: diastolic blood pressure; HR: heart rate; SBP:
systolic blood pressure; WBC: white blood cell. ∗Significant at 𝑝 < 0.05 and ∗∗significant at 𝑝 < 0.001.
Table 3: Regression model for predicting mortality of ICU patients with scrub typhus (𝑛 = 120).
Variables 𝛽 (SE) 𝑝 value Odds ratio 95% CI EXP (B)
Lower Upper
Age 0.061 (0.026) 0.019 1.063 1.010 1.118
Serum creatinine (>1.4 g/dl) −2.417 (0.840) 0.004 0.089 0.017 0.463
Model 𝜒2 = 76.137 (𝑝 < 0.001); −2 Log likelihood = 43.960; Cox & Snell 𝑅2 = 0.470; Nagelkerke 𝑅2 = 0.743; Hosmer and Lemeshow 𝑝 = 0.986.
to the findings of other studies [16, 17, 19, 23], though a study
reports a different finding [24]. Similarly, mortality was not
significantly influenced by WBC count (>11000 per mm3) in
this study. Although a similar finding has been documented
[24], most studies found the role of WBC count on mortality
[16, 17, 19, 23]. Evidences suggest that increase in leucocyte
count increase the RR of mortality by nearly one time [15, 17].
In sharp contrast to this, a study done by Varghese et al.
demonstrated that the effect of WBC count (<11,000/mm3)
on RR of mortality of patient infected with scrub typhus
is not significant [18]. Furthermore, our study also showed
no significant association between platelets count (<100000
per mm3) and mortality, which is similar to the results
reported by other studies in other countries [16, 19]. In
contrast to these findings, several studies conducted in Indian
settings reported increased risk of mortality in patients with
lower platelets count compared to those with higher platelet
count [15, 17, 25]. Similarly, bilirubin level (>1.5mg/dl) was
not associated with mortality in this study. Several studies
have also demonstrated no significant association between
bilirubin level and mortality [16, 17, 19]. However, one study
demonstrated that bilirubin level (>1.5mg/dl) significantly
increased the RR of mortality by 9.28 (1.48–58.5) times
[18]. Similarly, another study found serum bilirubin level
≥ 2.5mg/dl increased the risk of mortality by 3.1 (1.7–5.4)
times in comparison to level lower than 2.5mg/dl [15].
Likewise, our study did not find a significant association
between total protein level (<6 g/dl) and mortality, which
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is similar to other studies [17, 19]. There have been incon-
sistent reports in the literature with respect to the effect
of albumin level on mortality [16, 17, 19, 23, 24], and our
result suggests no significant association of serum albumin
level with mortality. Transaminase level (>120 IU/l) was
not associated with mortality in our study. Other studies
also demonstrated similar findings [16, 17, 24]. However,
a study in India reported that patients with comparatively
higher level of aspartate aminotransferase (AST) and alanine
aminotransferase (ALT) were associated with mortality [15,
23, 25]. Our study demonstrated significant association of
serum creatinine level (>1.4mg/dl) with mortality. Serum
creatinine level > 1.4mg/dl was found to be an independent
predictor of mortality, suggesting that the odds of mortality
in patients with serum creatinine level > 1.4mg/dl are 0.098
times higher as compared to those with serum creatinine
level ≤ 1.4mg/dl (𝑝 = 0.098; 95% CI = 0.016 to 0.580).
This finding is consistent with the previous finding reported
in other studies [18, 24, 26, 27]. Similarly, a study from
Nepal also reported AKI at the time of admission to be one
of the predictors of mortality, but without odds ratio [13].
Furthermore, another study reported that creatinine level >
2mg/dl independently increased odds for mortality by 3.5
(1.7–7.1) times in patients infected with scrub typhus [15].
Similarly, study by Sivarajan et al. demonstrated that serum
creatinine level > 1.5mg/dl is a predictor of mortality (OR =
18.03, 95% CI = 1.38 to 235.1) [25].
Our study showed that AKI requiring dialysis was asso-
ciated with mortality, which is consistent with the find-
ing of a previous study [20]. Moreover, a study has also
reported the need for dialysis as an independent predictor
for mortality [22]. This study demonstrated a significant
association betweenARDS andmortality; however, it was not
independently associated with mortality. However, previous
studies reported that ARDS to be an independent predic-
tor for mortality [19, 22]. Similarly, hypotension requiring
vasoactive agents [15, 17], or shock [19], has also been
known to be an independent predictor of mortality. But,
we did not observe such results in multivariate analysis.
Presence of meningoencephalitis, gastrointestinal bleeding,
pneumonia, arrhythmias, andmyocarditis was not associated
with mortality in this study, probably due to a lesser number
of patients suffering from these complications. Others studies
also reported CNS dysfunction [15], APACHE-II score [16,
20, 22], metabolic acidosis [19], altered sensorium [19, 27],
pneumonia [13], procalcitonin [22], and absence of eschar
[16] as independent predictors for mortality. SOFA score
[22], von Willebrand factor [28], high mobility group box
1 (HMGB1) [28], cytokine (interleukin-8) [29], endothelial
marker, andmacrophagemarker [30] are also associated with
poor outcome.
5. Conclusions
Older age and high serum creatinine were found to be
independent predictors of poor outcome in patients with
scrub typhus admitted in medical ICU of Chitwan Medical
College Teaching Hospital. Morbidity and mortality associ-
ated with scrub typhus can be reduced significantly by early
recommended empiric therapy with doxycycline in clinically
suspected cases of scrub typhus.
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